Posted by Michael Wonder on 15 Nov 2020
Life-saving spinal muscular atrophy medicine to be made available to Australian babies
15 November 2020 - Access to a life-saving and life-changing medicine will soon be expanded for Australian children and infants with spinal muscular atrophy, thanks to a breakthrough medicines listing on the Pharmaceutical Benefits Scheme.
From 1 December, subsidised access to the life-changing medicine Spinraza (nusinersen sodium) will be expanded to include children and infants genetically diagnosed with the most severe types of SMA before the onset of symptoms (pre-symptomatic).
